Amelia™-1 Study is testing if evexomostat can improve patients' safety and clinical response to a PI3K inhibitor plus an estrogen receptor degrader. Evexomostat, a novel MetAP2 inhibitor, controlled PI3K-induced hyperglycemia in the first study patient, consistent with pre-clinical data. Further, ctDNA data shows no evidence of residual PIK3CA mutation in blood after 6 weeks of treatment.

Historica Canada has released a new Heritage Minute commemorating the 100th anniversary of the beginning of research that would lead to the discovery of insulin.

Designed to Deliver the Best Injection Experience

Some of the major participants in the antidiabetics market share include Novo Nordisk, AstraZeneca, Bayer Corporation, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly, Halozyme Therapeutics, Johnson & Johnson, Merck & Co. Inc., Novartis AG, Oramed Pharmaceuticals Inc., Pfizer, Sanofi and Takeda Pharmaceutical.

Key Opinion Leader spreading awareness of diabetes endorses the company's liquid insulin mouth rinse solution for Type 2 diabetes and pre-diabetes patients

DRAP (Drug Regulatory Authority Pakistan) provided approval to commence studies of INSUGIN in Pakistan

Non-Dilutive Investment and Product License includes licensing fee and development costs

Advanced management of diabetes certificate course helps medical community better care for the diabetes pandemic.

EastGate to receive the first non-dilutive investment tranch from the total funding up to $5 million USD as per the terms of the Definitive Agreement.

Increase in the aging population, the rise in incidence & prevalence of diabetes, growing awareness for early prevention of diseases and a healthy lifestyle are expected to drive the market growth. Continuous development in insulin delivery has gained innovation in implementing pump therapy with next-generation insulin pumps.

Insulin Algorithms Software Makes Accurate Insulin Dosing Easy and Cost-Effective

Dimpflmeier Bakery Ltd. announces the release of their new CARB SMART™ bread, the world's first commercially available high-protein, ultra-low net carb all-natural bread that promises to satisfy both athletes and foodies.

Today, Global Research & Data Services is pleased to announce the publishing of our most recent set of data and market analyses for the insulin markets across many different countries around the world.

Driven by an increasing prevalence of diabetes, the total market for Insulin and Non-Insulin Antidiabetics is expected to reach sales worth US$ 2803 Million by 2015.

Mark your calendars now for the American Diabetes Association's 71st Scientific Sessions with one of the nation's leading Diabetic Suppliers Mini Pharmacy

After completing the clinical trial on over 30 patients with effectiveness at 100%, Sino Stem Cells, introduces diabetes clinically. 62.9% reduced insulin dosage by 50%. 3.7% of Type 1 and 11.1% of Type 2 could completely stop insulin injections.

Company foresees innovations in treatment and technology to counter condition that may strike one in three adults by mid-Century

Diabetics can now find help in curbing those high carb cravings through the use of chromium in the form of a spray.

Bayer's CONTOUR USB is the first and only blood glucose monitor that plugs directly into a computer providing users with instant access to information that can help optimize diabetes management.